borderline significancep = 0.052
Unexpectedly, although with borderline significance ( p = 0.052), there was lower FREM2 expression in LGG patients who progressed during first-line temozolomide treatment and had an IDH mutation versus patients with IDH -mutant stable/responsive disease; whereas there was no difference in IDH -WT patients ( Figure 6 ).